4.8 Article

Personalized characterization of diseases using sample-specific networks

Journal

NUCLEIC ACIDS RESEARCH
Volume 44, Issue 22, Pages -

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw772

Keywords

-

Funding

  1. Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13040700]
  2. National Program on Key Basic Research Projects [2014CB910504, 2012CB910800]
  3. National Natural Science Foundation of China (NSFC) [91529303, 61134013, 91439103, 61403363, 81430066, 81402276, 81402371, 81401898, 81402498, 81325015, 31370747, 81101583, 81372509, 81471047]
  4. Science and Technology Commission of Shanghai Municipality [15XD1504000]
  5. Key projects of natural science of Anhui Provincial Education Department [KJ2016A002]
  6. JSPS KAKENHI [15H05707]
  7. JST
  8. Grants-in-Aid for Scientific Research [15H05707] Funding Source: KAKEN

Ask authors/readers for more resources

A complex disease generally results not from malfunction of individual molecules but from dysfunction of the relevant system or network, which dynamically changes with time and conditions. Thus, estimating a condition-specific network from a single sample is crucial to elucidating the molecular mechanisms of complex diseases at the system level. However, there is currently no effective way to construct such an individual-specific network by expression profiling of a single sample because of the requirement of multiple samples for computing correlations. We developed here with a statistical method, i.e. a sample-specific network (SSN) method, which allows us to construct individual-specific networks based on molecular expressions of a single sample. Using this method, we can characterize various human diseases at a network level. In particular, such SSNs can lead to the identification of individual-specific disease modules as well as driver genes, even without gene sequencing information. Extensive analysis by using the Cancer Genome Atlas data not only demonstrated the effectiveness of the method, but also found new individual-specific driver genes and network patterns for various types of cancer. Biological experiments on drug resistance further validated one important advantage of our method over the traditional methods, i.e. we can even identify such drug resistance genes that actually have no clear differential expression between samples with and without the resistance, due to the additional network information.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available